Aevum is pioneering the discovery and development of therapeutic molecules derived from exercise to treat disease. Our lead program is a first-in-class therapy for the treatment of Parkinson’s and other related neurodegenerative disorders. Focus/Therapeutic Area: Neuro Stage/Status: Seed Website: —
Aevum Therapeutics Read More »
Advancing off-the-shelf dopamine neuron replacement therapies as a disease-modifying and potentially curative treatment for neurological disorders. Our proprietary platform leverages a novel approach to treating central nervous system disorders, such as Parkinson’s disease, by replacing neurons lost due to neurodegeneration. Focus/Therapeutic Area: Neuro Stage/Status: Series A Website: https://www.kenaitx.com
Kenai Therapeutics Read More »
Tortugas is developing therapeutics for neurological diseases of high unmet need. We focus on translational approaches to allow for rapid identification of efficacy and impact. Focus/Therapeutic Area: Neuro Stage/Status: Seed Website: https://www.tortugasneuro.com/
Tortugas Neuroscience Read More »
